Skip to content

Positive Emotional Processing: Exploring Novel Treatment Targets in Social Phobia

Positive Emotional Processing: Exploring Novel Treatment Targets in Social Phobia - New Data

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02136212
Enrollment
57
Registered
2014-05-12
Start date
2013-04-30
Completion date
2016-09-30
Last updated
2017-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Social Anxiety Disorder

Brief summary

The purpose of this study is to test the effects of a computerized approach/avoidance training (AAT) procedure in a sample of individuals diagnosed with social anxiety disorder (SAD). The training procedure is designed to modify automatic approach responses for positive social stimuli. Previous research has shown that a single administration of approach-positive AAT influences social behavior in the laboratory. The goal of this study is to examine the effects of a four-session AAT procedure on measures of positive social-emotional functioning. The investigators hypothesize that individuals assigned to the approach-positive AAT condition will demonstrate larger increases in positive affect and improvements in social relationship functioning from pre- to post-assessment compared to those assigned to the control condition.

Interventions

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
University of California, San Diego
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 18-55 * Principal psychiatric diagnosis of generalized social anxiety disorder * Liebowitz Social Anxiety Scale (LSAS) score ≥ 60 * Ability to read and speak English sufficiently to complete study procedures

Exclusion criteria

* History of psychosis, mania, or substance dependence * Current severe medical disorder that requires inpatient treatment or frequent medical follow ups including but not limited to: unstable hypertension, unstable angina, unstable diabetes mellitus, unstable cardiac arrhythmias, transient ischemic attacks, severe coronary artery disease, severe peripheral vascular disease, severe hepato-gastro-intestinal disease, severe infectious disease (e.g. HIV), recurrent severe headache or migraine, fainting spells, seizures, and history of traumatic brain injury with loss of consciousness \>30 minutes * Current use of the following medications: antidepressants, benzodiazepines, antipsychotics, mood stabilizers, or other drugs that can acutely affect the hemodynamic response (methylphenidate and acetazolamide) * Caffeine intake \>10 cups/day or recent significant changes in consumption * MRI exclusions, including claustrophobia, cardiac pacemaker, metal fragments in eyes/skin/body (shrapnel), aortic/aneurysm clips, prosthesis, by-pass surgery/coronary artery clips, hearing aid, heart valve replacement, shunt (ventricular or spinal), electrodes, metal plates/pins/screws/wires, or neuro/bio-stimulators (TENS unit), persons who have ever been a metal worker/welder, history of eye surgery/eyes washed out because of metal, women who are or may be pregnant (determined by a positive pregnancy test), women using an intrauterine device, vision problems uncorrectable with lenses, claustrophobia, inability to lie still on one's back for 60 minutes; prior neurosurgery; older tattoos with metal dyes; unwillingness to remove nose, ear, tongue, or face rings.

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in positive affect (Positive and Negative Affect Schedule)1 monthChange from pre- to post-assessment in positive affect.
Change from baseline in social connectedness (Social Connectedness Scale - Revised)1 monthChange from pre- to post-assessment in social connectedness.

Secondary

MeasureTime frameDescription
Change from baseline in social relationship functioning (Interpersonal Outcomes Scale)1 monthChange from pre- to post-assessment in frequency of social approach behaviors and relationship satisfaction.
Change from baseline in social anxiety symptoms (Liebowitz Social Anxiety Scale)1 monthChange from pre- to post-assessment in social anxiety symptoms.

Other

MeasureTime frameDescription
Change from baseline in blood oxygen level dependent (BOLD) response in the striatum, amygdala, and medial prefrontal cortex, as measured with functional magnetic resonance imaging (fMRI)1 monthChange from pre- to post-assessment in neural activation during social reward processing.
Change from baseline in social anxiety disorder (SAD) related psychopathology, including depression and anhedonia.1 monthChange from pre- to post-assessment in symptoms of depression and anhedonia

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026